Search
for
Research 10 of 1000+
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial The Lancet · 2023 · 227 citations
- A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata British Journal of Dermatology · 2013 · 205 citations
- The Rise in Adrenal Androgen Biosynthesis: Adrenarche Seminars in Reproductive Medicine · 2004 · 173 citations
- Rickets with alopecia: An inborn error of vitaminD metabolism 1979 · 170 citations
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention 2011 · 147 citations
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results Journal of the American Academy of Dermatology · 2021 · 138 citations
- Risk factors for prostate cancer: a case-control study in Greece International Journal of Cancer · 1999 · 127 citations
- 1,25-dihydroxyvitamin D resistance, rickets, and alopecia The American Journal of Medicine · 1984 · 110 citations
- Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study PLOS ONE · 2014 · 101 citations
- Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis Systems Biology in Reproductive Medicine · 2017 · 91 citations
All research results →